Use of doxinate with danthron as withdrawal therapy in the treatment of chronic functional constipation.
D000880:Anthraquinones; D003248:Constipation / Q000628:therapy*; D004143:Dioctyl Sulfosuccinic Acid; D006801:Humans; D013501:Surface-Active Agents / Q000627:therapeutic use*
D000880:Anthraquinones; D013501:Surface-Active Agents; C042834:9,10-anthraquinone; D004143:Dioctyl Sulfosuccinic Acid; C004315:danthron
ANTHRAQUINONE; CONSTIPATION/therapy; SURFACE-ACTIVE SUBSTANCES/therapeutic use